Research Directory

Q1 2017 stock market report: Biotechs climb to the top of the tree

Read more

MedNous Briefing - The European Medicine Agency's PRIME Scheme

Read more

The story behind the discovery of Keytruda

Read more

Biotechs post higher values in 2016 fourth quarter

Read more

Market Commentary: How risky are European biotechs?

Read more

The stately progress of antibiotics

Read more

Market Analysis: The outlook for European pharma

Read more

New risk capital for European companies

Read more

Debate heats up over germline editing

Read more

Q3 stock market performance

Read more